
Andrea Necchi/LinkedIn
Jun 1, 2025, 14:48
First results of SURE-02 Trial presented at ASCO 2025 by Andrea Necchi
Chiara Mercinelli, GU Medical Oncologist at IRCCS San Raffaele Hospital, shared on X:
“My mentor Andrea Necchi delivered a brilliant presentation today at ASCO 2025!
44% cCR in MIBC with Sacituzumab Govitecan and Pembrolizumab combination in SURE2 trial led to promising biomarker results that could guide future therapeutic choices.
So proud to be part of this wonderful team at San Raffaele Hospital!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40
Jun 2, 2025, 15:37
Jun 2, 2025, 15:20